Literature DB >> 1353008

Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences.

G Holmgren1, S Bergström, U Drugge, E Lundgren, C Nording-Sikström, O Sandgren, L Steen.   

Abstract

Familial amyloidotic polyneuropathy (FAP) with a mutation in position 30 of transthyretin (TTR) (previously called prealbumin) is an autosomal dominant inherited disorder characterized by varying degrees of peripheral neuropathy, nephropathy, gastrointestinal problems, and vitreous amyloid. We have earlier diagnosed homozygosity for the TTR-Met30-gene using Southern analysis in four Swedish individuals. We have found it possible to detect homozygosity for the Met-30 mutation by amplifying discrete regions of the TTR-gene using polymerase chain reaction (PCR), and the amplification products restricted with NsiI analysed by gel electrophoresis. Clinical data on seven homozygous individuals, including three new cases, are presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353008     DOI: 10.1111/j.1399-0004.1992.tb03627.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Authors:  Christine E Bulawa; Stephen Connelly; Michael Devit; Lan Wang; Charlotte Weigel; James A Fleming; Jeff Packman; Evan T Powers; R Luke Wiseman; Theodore R Foss; Ian A Wilson; Jeffery W Kelly; Richard Labaudinière
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.

Authors:  Y Takaoka; F Tashiro; S Yi; S Maeda; K Shimada; K Takahashi; Y Sakaki; K Yamamura
Journal:  Transgenic Res       Date:  1997-07       Impact factor: 2.788

3.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.

Authors:  K Yamamoto; S Ikeda; N Hanyu; S Takeda; N Yanagisawa
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

4.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Authors:  D R Jacobson; M Ittmann; J N Buxbaum; R Wieczorek; P D Gorevic
Journal:  Tex Heart Inst J       Date:  1997

5.  Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.

Authors:  Urban Hellman; Flora Alarcon; Hans-Erik Lundgren; Ole B Suhr; Catherine Bonaiti-Pellié; Violaine Planté-Bordeneuve
Journal:  Amyloid       Date:  2008-09       Impact factor: 7.141

6.  Epidermolysis bullosa simplex: a keratin 5 mutation is a fully dominant allele in epidermal cytoskeleton function.

Authors:  K Stephens; A Zlotogorski; L Smith; P Ehrlich; E Wijsman; R J Livingston; V P Sybert
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

7.  Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

Authors:  G Holmgren; P M Costa; C Andersson; K Asplund; L Steen; L Beckman; P O Nylander; A Teixeira; M J Saraiva; P P Costa
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

8.  Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.

Authors:  K Kohno; J A Palha; K Miyakawa; M J Saraiva; S Ito; T Mabuchi; W S Blaner; H Iijima; S Tsukahara; V Episkopou; M E Gottesman; K Shimada; K Takahashi; K Yamamura; S Maeda
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.